Enlight Energy — Director's Dealing 2026

Jun 3, 2026

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 33(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287

Estimated average burden hours per response 0.5

☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Cohen Israeli Ayelet (Last) (First) (Middle) C/O ENLIGHT RENEWABLE ENERGY LTD. 13 AMAL ST. AFEK INDUSTRIAL PARK (Street) ROSH HAAYIN	2. Issuer Name and Ticker or Trading Symbol Enlight Renewable Energy Ltd. [ ENLT ] 2a. Foreign Trading Symbol ENLT	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP OPERATIONS
(City) (State) (Zip/Postal Code) ISRAEL (Country)	3. Date of Earliest Transaction (Month/Day/Year) 06/01/2026
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---	---	---
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)
Ordinary shares, NIS 0.1 par value per share	06/01/2026
Ordinary shares, NIS 0.1 par value per share	06/01/2026
Ordinary shares, NIS 0.1 par value per share	06/01/2026
Ordinary shares, NIS 0.1 par value per share	06/01/2026
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---	---
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)
Stock Options (right to buy)	$23.22(3)	06/01/2026
Stock Options (right to buy)	$27.33(7)

Explanation of Responses:

---

1. Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.

2. Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

3. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

4. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

5. Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.

6. Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.

7. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

8. Stock options were granted on October 1, 2025, with 12,732 vesting on each of October 1, 2026 and October 1, 2028, and 12,733 vesting on each of October 1, 2027 and October 1, 2029.

9. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

/s/ Helit Megido as attorney-in-fact for Ayelet
Cohen Israeli
06/02/2026
** Signature of Reporting Person
Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.